The expected return from pharmaceutical research: sources of new drugs and the profitability of R & D investment (Record no. 302868)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 00666nam a2200181Ia 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 140323b1975 xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0844731595 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 338.476150973 |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Schwartzman, David |
| 9 (RLIN) | 103969 |
| 245 ## - TITLE STATEMENT | |
| Title | The expected return from pharmaceutical research: sources of new drugs and the profitability of R & D investment |
| Statement of responsibility, etc. | Schwartzman, David |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Washington, D.C. |
| Name of publisher, distributor, etc. | American Enterprise Inst. for Public Policy Research |
| Date of publication, distribution, etc. | 1975 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 57 p. |
| 365 ## - TRADE PRICE | |
| Price amount | USD 3.00 |
| 440 ## - SERIES STATEMENT/ADDED ENTRY--TITLE | |
| Title | Evaluative studies, 19 |
| 9 (RLIN) | 47247 |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pharmaceutical research - Economic aspects - United States |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Book |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dewey Decimal Classification | Ahmedabad | Ahmedabad | 04/05/2009 | 338.476150973 S2E9 | 81535 | 04/09/2009 | 04/09/2009 | Book |